Post by Khalid Usmani

📰 The World of Pharma This Week – June 2026 Edition Dr. Reddy’s Oncology Success Phase III success for its biosimilar trastuzumab, paving the way for global filings in oncology. Zydus Dengue Vaccine Trials DCGI approved Phase III trials for its indigenous dengue vaccine candidate — India’s first home‑grown dengue solution. Cipla Smart Inhaler Launch Introduced a Bluetooth‑enabled inhaler for asthma and COPD, enabling real‑time adherence tracking. Biocon Biologics Global Expansion Announced biosimilar partnerships in Latin America and Southeast Asia, widening India’s biologics footprint. Sun Pharma Oncology Collaboration Deepened alliance with Daiichi Sankyo to co‑develop precision oncology molecules. Global Pharma Highlights • Pfizer’s AI‑driven antibiotic discovery platform showed promising early data. • Novartis completed a $1.2 billion acquisition of Mariana Therapeutics. • Moderna initiated Phase I trials for its RSV‑COVID dual vaccine in Europe. 👉 With India’s pharma sector advancing through biosimilars, smart devices, and global collaborations, which of these developments do you think will most shape the industry’s trajectory in 2026? #PharmaNews #DrugDiscovery #PharmaInsights #PharmaFuture #PharmaLeadership #PharmaGrowth